Share
Save
The Plastic Exposure Reduction Transforms Health Trial
The goal of this randomized controlled trial is to learn if an intervention of reducing plastic exposure through diet, personal care and cleaning products can improve health outcomes in adult participants with cardiometabolic risk factors. The main questions it aims to answer are: * Will the low plastic exposure intervention reduce urinary excretion of bisphenols? * Will the low plastic exposure intervention reduce urinary excretion of phthalate metabolites? * Can reducing plastic exposure improve cardiometabolic biomarkers? Researchers will compare this 4-week low plastic intervention with a control/no intervention group. Participants in the intervention group will: * be provided with food that have no/low plastic and plastic-associated chemicals * be provided with personal care and cleaning produces that have no/low plastic and plastic-associated chemicals * replace cooking and food preparation equipment with no/low plastic alternatives Participants in the control group will not receive the intervention and are not expected to change their behaviour.
All participants will provide biological samples (urine, stool, nasal lavage and blood) at several timepoints during the study and attend 4 clinic visits: screening and before, during and after the intervention. Participants will also complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.
Study details:
Many plastic products contain endocrine disrupting chemicals, such as bisphenols and phthalates (referred to as plastic-associated chemicals or PAC), which leach out from everyday use and enter the human body. Food contaminated from packaging or with plastic particles, personal care and cleaning products may be sources of PAC which can be inhaled or absorbed through the skin. The fundamental premise underpinning the research is that exposure to PAC, combined with genetic and lifestyle factors, creates chronic and systemic inflammation that underpins cardiometabolic conditions.
This randomized controlled trial aims to demonstrate whether decreasing exposure to plastic and PAC will reduce urinary excretion of PAC and improve cardiometabolic biomarkers in people with cardiometabolic risk factors. Participants that have consented and passed health screening (N=60) will be randomized to one of two parallel groups, to receive a 4-week low plastic intervention in their homes with the support of registered dietitians. * Group 1 (N=30): low plastic intervention group.
* Group 2 (N=30): control/no intervention group. All participants will attend four in-person clinic appointments, one during screening, and three during the intervention (Visit 1: day 0, baseline; Visit 2: day 16, midpoint; and Visit 3: day 29, post intervention), of up to two hours duration each. In addition, participants will have a video/phone appointment between screening and Visit 1.
The day before and after the video/phone appointment, participants will be asked to collect urine, stool and nasal washing samples and send them back the day after their video/phone appointment. At the end of the video/phone appointment, eligible and willing participants will be invited to continue to the intervention study and randomized into either the intervention or control group. At the video/phone appointment, participants from Group 1 will order their food and personal care products.
The researchers will send the order to a local meal service delivery who will order, pay for, package, and deliver the approved food to the participants' homes in insulated boxes. Delivery of approved products to participants' homes will take place the day before the intervention begins, and at other pre-determined timepoints throughout the study, as required. Samples of food products will be frozen for retrospective testing for PAC, if exposure testing indicates contamination from an unexpected source.
Participants from Group 1 will use only non-plastic cooking utensils provided by the researchers and follow guidance concerning the preparation of their food. Participants from Group 1 will use only personal care and cleaning products supplied by the research team. Personal care products include, but are not limited to shampoo, conditioners, face moisturizers, cleansers, serums, make-up and sunscreens, deodorant, tampons and applicators.
Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention. All participants will be asked to collect urine, stool, and nasal washing samples on days -1, 8, 15, 22 and 28 of the intervention period, and return them at the clinic visits. During the clinic visits, participants will have fasting blood sample taken, complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall - plastic exposure (24DR-PE) of food consumed, and how it was stored prepared, and consumed.
The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake. For intervention adherence the following assessment tools will be employed:. 24-hour dietary recall - plastic exposure interview (24DR-PE): This assessment is a researcher-administered, computer-assisted, 24-hour dietary recall interview.
The method assesses dietary intake on the preceding 24-hour period. The method is adapted to gather additional information concerning the packaging, storage, and preparation of food by the participants. Trained dietitians will carry out the interviews during the clinic visits.
The interviews will vary in length between 15 and 60 minutes depending on the stage of the study, and the complexity of each participants' diet. They will be carried out once during screening and three times during the 4-week intervention. 24-hour personal care product recall (24HR-PPR): This is a self-administered questionnaire for the 24-hour recall of personal care products use.
This assessment will be conducted once during screening and three times during the 4-week intervention. The questionnaire consists of 15 questions and will take between 2 and 5 minutes to complete. Post-trial survey: This survey will be conducted to identify any difficulties experienced by the participants that might have affected their adherence to the intervention and procedures.
Tolerability and feasibility qualitative interview: To evaluate the tolerability and feasibility of the trial intervention, participants will be invited to participate in a phone interview within two weeks of completing the intervention. A trained interviewer will conduct the interviews using a structured guide that includes both closed and open-ended questions. Each interview is expected to last 20-40 minutes.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Exclusion criteria
Eligibility
Age eligible for study : 18 and older
Healthy volunteers accepted : Yes
Gender eligible for study: All
Things to know
Study dates
Study start: 2024-09-05
Primary completion: 2025-06-01
Study completion finish: 2025-06-01
Study type
PREVENTION
Phase
NA
Trial ID
NCT06571994
Intervention or treatment
BEHAVIORAL: Low Plastic Intervention
Conditions
- • Endocrine Disruptors
- • Inflammation
- • Cardiometabolic Risk Factors
Find a site
Closest Location:
Harry Perkins Institute of Medical Research
Research sites nearby
Select from list below to view details:
Harry Perkins Institute of Medical Research
Nedlands, Western Australia, Australia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Participant Group/Arm | Intervention/Treatment |
---|---|
EXPERIMENTAL: Low Plastic Intervention Group
| BEHAVIORAL: Low Plastic Intervention
|
NO_INTERVENTION: Control Group
| Not specified |
What is the study measuring?
Primary outcome
Primary Outcome Measure | Primary Outcome Description | Primary Outcome Time Frame |
---|---|---|
Changes in urinary excretion of plastic-associated chemicals (composite of mono-n-butyl phthalate, MnBP; mono benzyl phthalate, MBzP; and bisphenol A, BPA) | Assessed by measuring urinary concentrations (ng/mL) of MnBP, MBzP and BPA and comparing change in the composite outcome | Baseline and 4 weeks for both groups |
Secondary outcome
Secondary Outcome Measure | Secondary Outcome Description | Secondary Outcome Time Frame |
---|---|---|
Changes in urinary excretion of mono-n-butyl phthalate (MnBP) | Assessed by measuring urinary concentrations of MnBP (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of mono benzyl phthalate (MBzP) | Assessed by measuring urinary concentrations of MBzP (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of mono ethyl phthalate (MEP) | Assessed by measuring urinary concentrations of MEP (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of mono-iso-butyl phthalate (MiBP) | Assessed by measuring urinary concentrations of MiBP (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of mono-n-octyl phthalate (MnOP) | Assessed by measuring urinary concentrations of MnOP (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of di-(2-ethylhexyl) phthalate (DEHP) | Assessed by measuring urinary concentrations of the composite of DEHP metabolites (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of bisphenol A (BPA) | Assessed by measuring urinary concentrations BPA (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of bisphenol F (BPF) | Assessed by measuring urinary concentrations BPF (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in urinary excretion of bisphenol S (BPS) | Assessed by measuring urinary concentrations BPS (ng/mL) and compare mean % change | Baseline, and 1, 2, 3 and 4 weeks for both groups |
Changes in Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) | Assessed by measuring insulin (microU/L) x glucose (nmol/L) / 22.5 in fasting blood samples | Baseline, and 2 and 4 weeks for both groups |
Changes in fasting serum triglycerides | Assessed by measuring triglycerides (mmol/L) in fasting blood samples | Baseline, and 2 and 4 weeks for both groups |
Changes in high sensitivity C-reactive protein (hsCRP) | Assessed by measuring hsCRP (mg/L) in fasting blood samples | Baseline, and 2 and 4 weeks for both groups |
Changes in body composition | Assessed by measuring mass, fat free mass, visceral adipose tissue, and skeletal muscle mass | Baseline, and 2 and 4 weeks for both groups |
Changes in waist circumference | Assessed by using a non-stretchable tape measure to obtain waist circumference | Baseline, and 2 and 4 weeks for both groups |
Changes in blood pressure | Assessed by measuring systolic/diastolic blood pressue | Baseline, and 2 and 4 weeks for both groups |
Frequently Asked Questions
Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol
No questions submitted. Be the first to ask a question!